BMS-247550 in Treating Patients With Advanced Cancers

NIAID Data Ecosystem2026-03-06 收录

肿瘤药物临床试验

肿瘤机制研究

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2005268 数据链接链接失效反馈

官方服务：

资源简介：

Phase I trial to study the effectiveness of BMS-247550 in treating patients who have malignant solid tumors or lymphoma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

创建时间：

2000-11-15

Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma

肉瘤靶向治疗

肿瘤药物临床试验

The purpose of this study is to evaluate the activity and tolerability of pazopanib in subjects with advanced and/or metastatic soft tissue sarcoma who have relapsed following standard therapies or fo

DataCite Commons2025-12-16 更新70

ABM_Source_结肠隐窝失巢凋亡计算模型模拟数据_存档

生物学建模

肿瘤机制研究

本数据集为结肠隐窝失巢凋亡的基于代理模型（ABM）模拟数据，聚焦结直肠癌（CRC）发生机制研究。模型包含隐窝口腔几何结构精准表征等新特性，模拟再现了细胞死亡局限于隐窝口腔小区域等与体内观察一致的涌现行为，支持探究隐窝细胞数量调控机制及细胞形状假设对生物学行为的影响。论文“An agent-based model of anoikis in the colon crypt displays nov

海数据20

A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK2126458 in Subjects With Solid Tumors or Lymphoma

肿瘤药物临床试验

药效学研究

P3K112826 is a Phase I, first-time-in-human dose escalation study in subjects with refractory malignancy. The primary objective of this study is to determine the recommended Phase II dose of GSK212645

DataCite Commons2025-05-01 更新00

Supplementary Material for: Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA*

乳腺癌新辅助治疗

肿瘤药物临床试验

Background: Sorafenib was tested for neoadjuvant treatment with an anthracycline/taxane-based chemotherapy in the open-label, multicentre, single-arm phase II study, ‘SOFIA'. Patients and Methods: Inc

Figshare2017-06-20 更新30

Gene Expression Analysis Indicates Divergent Mechanisms in DEN-Induced Carcinogenesis in Wild Type and Bid-Deficient Livers

肿瘤机制研究

基因表达谱分析

Bid is a Bcl-2 family protein. In addition to its pro-apoptosis function, Bid can also promote cell proliferation, maintain S phase checkpoint, and facilitate inflammasome activation. Bid plays import

NIAID Data Ecosystem20

BMS-247550 in Treating Patients With Advanced Cancers

资源简介：

相关数据集